Provided by Tiger Fintech (Singapore) Pte. Ltd.

Dare Bioscience

2.84
-0.2500-8.09%
Pre-market: 2.840.00000.00%08:30 EDT
Volume:4.84M
Turnover:15.08M
Market Cap:25.14M
PE:-14.56
High:3.19
Open:3.05
Low:2.80
Close:3.09
Loading ...
Apr 08, 2021

Major Issues Report

8-K - Current report
Apr 05, 2021

Correspondence

CORRESP [Cover] - Correspondence
Mar 30, 2021

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 30, 2021

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Mar 08, 2021

Major Issues Report

8-K - Current report
Feb 16, 2021

Major Issues Report

8-K - Current report
Feb 12, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 10, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 09, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 08, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 01, 2021

Major Issues Report

8-K - Current report
Jan 11, 2021

Major Issues Report

8-K - Current report
Jan 06, 2021

Correspondence

CORRESP [Cover] - Correspondence
Jan 05, 2021

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
Jan 04, 2021

Correspondence

CORRESP [Cover] - Correspondence
Jan 04, 2021

Correspondence

CORRESP [Cover] - Correspondence
Dec 23, 2020

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
Dec 22, 2020

Public Prospectus

S-1 - General form for registration of securities under the Securities Act of 1933
Dec 09, 2020

Major Issues Report

8-K - Current report
Dec 07, 2020

Major Issues Report

8-K - Current report